Alison Bauer
Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinogenesis | 5 | 2020 | 228 | 1.780 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 5 | 2021 | 27 | 1.740 |
Why?
| | Pneumonia | 10 | 2026 | 636 | 1.620 |
Why?
| | Lung Neoplasms | 16 | 2024 | 2664 | 1.540 |
Why?
| | Butylated Hydroxytoluene | 9 | 2020 | 37 | 1.250 |
Why?
| | Lung | 14 | 2026 | 4106 | 1.190 |
Why?
| | Mast Cells | 4 | 2026 | 147 | 1.170 |
Why?
| | Carcinogens | 5 | 2017 | 123 | 1.160 |
Why?
| | Toll-Like Receptor 4 | 4 | 2016 | 276 | 1.150 |
Why?
| | Formaldehyde | 1 | 2025 | 65 | 0.870 |
Why?
| | Anthracenes | 4 | 2023 | 31 | 0.870 |
Why?
| | Ozone | 6 | 2011 | 115 | 0.850 |
Why?
| | Lightning | 1 | 2023 | 2 | 0.780 |
Why?
| | Lightning Injuries | 1 | 2023 | 4 | 0.780 |
Why?
| | Mice, Inbred BALB C | 10 | 2020 | 1261 | 0.780 |
Why?
| | Signal Transduction | 6 | 2019 | 5216 | 0.740 |
Why?
| | Methylcholanthrene | 3 | 2020 | 21 | 0.740 |
Why?
| | Inflammation Mediators | 1 | 2025 | 506 | 0.720 |
Why?
| | Fluorenes | 2 | 2019 | 45 | 0.700 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2013 | 101 | 0.690 |
Why?
| | Sports | 1 | 2023 | 211 | 0.640 |
Why?
| | Genetic Predisposition to Disease | 8 | 2010 | 2378 | 0.610 |
Why?
| | Eicosanoids | 1 | 2019 | 58 | 0.570 |
Why?
| | Mice | 30 | 2026 | 18329 | 0.550 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 121 | 0.540 |
Why?
| | Mucin 5AC | 1 | 2018 | 71 | 0.540 |
Why?
| | Air Pollutants | 4 | 2020 | 405 | 0.510 |
Why?
| | Mitogens | 1 | 2017 | 55 | 0.510 |
Why?
| | Animals | 35 | 2026 | 38030 | 0.510 |
Why?
| | Benzene | 4 | 2005 | 18 | 0.490 |
Why?
| | Inflammation | 6 | 2017 | 2878 | 0.490 |
Why?
| | Lung Injury | 3 | 2026 | 244 | 0.480 |
Why?
| | Epiregulin | 1 | 2016 | 2 | 0.480 |
Why?
| | Acetylcysteine | 1 | 2016 | 139 | 0.450 |
Why?
| | Military Personnel | 1 | 2023 | 737 | 0.440 |
Why?
| | Lung Diseases | 4 | 2017 | 780 | 0.440 |
Why?
| | Pulmonary Alveoli | 1 | 2017 | 385 | 0.440 |
Why?
| | Tobacco Smoke Pollution | 1 | 2017 | 227 | 0.430 |
Why?
| | Gene Deletion | 2 | 2016 | 391 | 0.410 |
Why?
| | Adenocarcinoma | 3 | 2016 | 925 | 0.410 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 1189 | 0.400 |
Why?
| | Nanotubes, Carbon | 3 | 2020 | 46 | 0.400 |
Why?
| | Epithelial Cells | 6 | 2020 | 1131 | 0.390 |
Why?
| | Gap Junctions | 4 | 2020 | 67 | 0.380 |
Why?
| | Urethane | 3 | 2011 | 43 | 0.370 |
Why?
| | Mitogen-Activated Protein Kinases | 4 | 2020 | 288 | 0.360 |
Why?
| | Dendritic Cells | 2 | 2026 | 499 | 0.360 |
Why?
| | Gene Expression Profiling | 4 | 2018 | 1767 | 0.350 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2016 | 1443 | 0.350 |
Why?
| | Connexin 43 | 3 | 2017 | 36 | 0.350 |
Why?
| | Ethanol | 1 | 2016 | 631 | 0.340 |
Why?
| | Enzyme Activation | 3 | 2019 | 762 | 0.330 |
Why?
| | Cell Communication | 3 | 2020 | 328 | 0.330 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2011 | 75 | 0.330 |
Why?
| | Cell Line | 5 | 2020 | 2823 | 0.320 |
Why?
| | Vanadium Compounds | 1 | 2010 | 2 | 0.320 |
Why?
| | Immunity, Innate | 1 | 2016 | 835 | 0.310 |
Why?
| | Oxidative Stress | 1 | 2016 | 1356 | 0.290 |
Why?
| | Bronchoalveolar Lavage Fluid | 4 | 2025 | 638 | 0.290 |
Why?
| | Cyclooxygenase 2 | 2 | 2019 | 166 | 0.260 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2019 | 2028 | 0.250 |
Why?
| | Air Pollution | 1 | 2010 | 314 | 0.250 |
Why?
| | Molecular Weight | 2 | 2019 | 312 | 0.240 |
Why?
| | Hematologic Diseases | 2 | 2003 | 66 | 0.230 |
Why?
| | Bone Marrow Cells | 3 | 2003 | 321 | 0.230 |
Why?
| | Quantitative Trait, Heritable | 2 | 2002 | 113 | 0.210 |
Why?
| | Unnecessary Procedures | 1 | 2024 | 54 | 0.210 |
Why?
| | Epoxide Hydrolases | 2 | 2005 | 13 | 0.210 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 2 | 2005 | 36 | 0.210 |
Why?
| | Mice, Inbred C57BL | 6 | 2026 | 5983 | 0.200 |
Why?
| | Brain | 1 | 2016 | 2947 | 0.200 |
Why?
| | DNA Damage | 3 | 2020 | 437 | 0.190 |
Why?
| | Precancerous Conditions | 1 | 2024 | 166 | 0.190 |
Why?
| | Mutation | 4 | 2018 | 4075 | 0.190 |
Why?
| | Acute Lung Injury | 1 | 2026 | 305 | 0.190 |
Why?
| | Organophosphonates | 1 | 2023 | 95 | 0.180 |
Why?
| | Chemokines | 2 | 2016 | 217 | 0.180 |
Why?
| | Occupational Injuries | 1 | 2023 | 47 | 0.180 |
Why?
| | Phosphorylation | 2 | 2019 | 1707 | 0.180 |
Why?
| | Mice, Inbred Strains | 5 | 2014 | 396 | 0.180 |
Why?
| | Preoperative Care | 1 | 2024 | 380 | 0.180 |
Why?
| | Saccharum | 1 | 2023 | 77 | 0.180 |
Why?
| | Chromosome Mapping | 2 | 2002 | 506 | 0.170 |
Why?
| | Heat Stress Disorders | 1 | 2023 | 84 | 0.170 |
Why?
| | Benz(a)Anthracenes | 1 | 2021 | 2 | 0.170 |
Why?
| | Benzopyrenes | 1 | 2021 | 4 | 0.170 |
Why?
| | Time Factors | 3 | 2019 | 7123 | 0.170 |
Why?
| | Nanofibers | 1 | 2020 | 23 | 0.160 |
Why?
| | Male | 16 | 2026 | 72842 | 0.160 |
Why?
| | Macrophages | 2 | 2021 | 1507 | 0.160 |
Why?
| | Mustard Gas | 1 | 2021 | 77 | 0.160 |
Why?
| | Hot Temperature | 2 | 2023 | 396 | 0.160 |
Why?
| | Cell Movement | 1 | 2025 | 959 | 0.160 |
Why?
| | Chemical Warfare Agents | 1 | 2021 | 89 | 0.160 |
Why?
| | Printing | 1 | 2019 | 5 | 0.150 |
Why?
| | Paper | 1 | 2019 | 9 | 0.150 |
Why?
| | Electrocardiography | 1 | 2023 | 665 | 0.150 |
Why?
| | Athletes | 1 | 2023 | 424 | 0.150 |
Why?
| | Group IV Phospholipases A2 | 1 | 2019 | 46 | 0.150 |
Why?
| | Nitrogen | 1 | 2019 | 125 | 0.140 |
Why?
| | Occupational Exposure | 1 | 2023 | 355 | 0.140 |
Why?
| | Bronchi | 1 | 2020 | 263 | 0.140 |
Why?
| | Cell Degranulation | 1 | 2018 | 40 | 0.140 |
Why?
| | Inhalation Exposure | 3 | 2020 | 103 | 0.140 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 264 | 0.140 |
Why?
| | Cytochrome P-450 CYP1B1 | 1 | 2017 | 5 | 0.130 |
Why?
| | DNA Adducts | 1 | 2017 | 16 | 0.130 |
Why?
| | Benzo(a)pyrene | 1 | 2017 | 8 | 0.130 |
Why?
| | Monocytes | 1 | 2021 | 539 | 0.130 |
Why?
| | Particulate Matter | 2 | 2019 | 326 | 0.130 |
Why?
| | Silver | 1 | 2018 | 36 | 0.130 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 167 | 0.130 |
Why?
| | Survival Analysis | 2 | 2018 | 1374 | 0.130 |
Why?
| | Air Pollution, Indoor | 1 | 2019 | 171 | 0.130 |
Why?
| | Disease Models, Animal | 4 | 2026 | 4560 | 0.130 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 254 | 0.130 |
Why?
| | Environmental Monitoring | 1 | 2019 | 346 | 0.120 |
Why?
| | Algorithms | 1 | 2024 | 1845 | 0.120 |
Why?
| | Humans | 17 | 2024 | 145474 | 0.120 |
Why?
| | Lipid Peroxides | 1 | 2016 | 10 | 0.120 |
Why?
| | Electronic Health Records | 1 | 2024 | 1196 | 0.120 |
Why?
| | Glutathione Peroxidase | 1 | 2016 | 41 | 0.120 |
Why?
| | Chick Embryo | 1 | 2016 | 132 | 0.120 |
Why?
| | Up-Regulation | 1 | 2019 | 847 | 0.120 |
Why?
| | Bronchoalveolar Lavage | 1 | 2016 | 89 | 0.120 |
Why?
| | Brain Chemistry | 1 | 2016 | 119 | 0.120 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 96 | 0.120 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 977 | 0.110 |
Why?
| | Environment | 1 | 2017 | 293 | 0.110 |
Why?
| | ErbB Receptors | 1 | 2018 | 635 | 0.110 |
Why?
| | Allergens | 1 | 2018 | 386 | 0.110 |
Why?
| | Climate Change | 1 | 2017 | 177 | 0.110 |
Why?
| | Particle Size | 3 | 2020 | 381 | 0.100 |
Why?
| | Glutathione | 1 | 2016 | 370 | 0.100 |
Why?
| | Withania | 1 | 2014 | 5 | 0.100 |
Why?
| | Heart Diseases | 1 | 2017 | 341 | 0.100 |
Why?
| | Inactivation, Metabolic | 2 | 2003 | 9 | 0.100 |
Why?
| | Metabolomics | 1 | 2019 | 732 | 0.100 |
Why?
| | Kelch-Like ECH-Associated Protein 1 | 1 | 2013 | 18 | 0.100 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2188 | 0.100 |
Why?
| | Cell Differentiation | 1 | 2021 | 2046 | 0.090 |
Why?
| | Fatty Acids | 1 | 2016 | 457 | 0.090 |
Why?
| | Genomics | 1 | 2018 | 825 | 0.090 |
Why?
| | Cell Membrane | 1 | 2016 | 707 | 0.090 |
Why?
| | Blood-Brain Barrier | 1 | 2014 | 160 | 0.090 |
Why?
| | Mice, Inbred A | 2 | 2010 | 48 | 0.090 |
Why?
| | Environmental Exposure | 1 | 2017 | 578 | 0.090 |
Why?
| | Plant Extracts | 1 | 2014 | 188 | 0.090 |
Why?
| | Mice, Knockout | 5 | 2026 | 3124 | 0.090 |
Why?
| | Cell Death | 1 | 2013 | 382 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1321 | 0.080 |
Why?
| | Gene Expression | 1 | 2016 | 1476 | 0.080 |
Why?
| | Species Specificity | 2 | 2010 | 546 | 0.080 |
Why?
| | Transcriptome | 1 | 2017 | 1038 | 0.080 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2011 | 119 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2013 | 456 | 0.080 |
Why?
| | Genes, Neoplasm | 1 | 2009 | 26 | 0.080 |
Why?
| | Prognosis | 1 | 2018 | 4316 | 0.070 |
Why?
| | Disease Progression | 2 | 2024 | 2864 | 0.070 |
Why?
| | Surface Properties | 2 | 2020 | 386 | 0.070 |
Why?
| | Transcription Factor AP-1 | 2 | 2007 | 79 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 848 | 0.070 |
Why?
| | Interleukin-10 | 1 | 2010 | 309 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2597 | 0.070 |
Why?
| | Scavenger Receptors, Class A | 1 | 2007 | 12 | 0.060 |
Why?
| | Antineoplastic Agents | 2 | 2013 | 2214 | 0.060 |
Why?
| | Micronucleus Tests | 2 | 2005 | 6 | 0.060 |
Why?
| | Oxidants | 1 | 2007 | 99 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 1 | 2013 | 981 | 0.060 |
Why?
| | Cell Survival | 2 | 2020 | 1100 | 0.060 |
Why?
| | Cytochrome P-450 CYP2E1 | 2 | 2003 | 30 | 0.060 |
Why?
| | Macrophages, Alveolar | 2 | 2007 | 373 | 0.060 |
Why?
| | Microsomes, Liver | 2 | 2003 | 85 | 0.060 |
Why?
| | Cyclins | 2 | 2003 | 79 | 0.060 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2003 | 105 | 0.060 |
Why?
| | Nitric Oxide Synthase | 2 | 2005 | 234 | 0.060 |
Why?
| | Receptors, Immunologic | 1 | 2007 | 208 | 0.060 |
Why?
| | Neoplasm Staging | 1 | 2009 | 1471 | 0.060 |
Why?
| | Cytokines | 2 | 2021 | 2067 | 0.060 |
Why?
| | NF-kappa B | 2 | 2007 | 666 | 0.060 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3542 | 0.060 |
Why?
| | Prostaglandins | 1 | 2005 | 94 | 0.050 |
Why?
| | Administration, Inhalation | 2 | 2003 | 571 | 0.050 |
Why?
| | RNA, Messenger | 4 | 2010 | 2803 | 0.050 |
Why?
| | Female | 5 | 2024 | 78844 | 0.050 |
Why?
| | Chronic Disease | 1 | 2009 | 1808 | 0.050 |
Why?
| | Phosphites | 1 | 2023 | 1 | 0.050 |
Why?
| | Bone Marrow | 1 | 2005 | 306 | 0.050 |
Why?
| | Hydrocarbons, Brominated | 1 | 2023 | 5 | 0.050 |
Why?
| | Mutagens | 1 | 2003 | 27 | 0.050 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2003 | 58 | 0.050 |
Why?
| | Nitric Oxide | 2 | 2005 | 892 | 0.050 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2005 | 337 | 0.050 |
Why?
| | Methacrylates | 1 | 2023 | 119 | 0.050 |
Why?
| | Lod Score | 1 | 2002 | 62 | 0.050 |
Why?
| | Models, Biological | 1 | 2009 | 1764 | 0.050 |
Why?
| | Anticarcinogenic Agents | 1 | 2002 | 62 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2007 | 1217 | 0.040 |
Why?
| | Transcription Factors | 1 | 2010 | 1734 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2009 | 3413 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2005 | 435 | 0.040 |
Why?
| | Mechlorethamine | 1 | 2021 | 52 | 0.040 |
Why?
| | Leukocytes | 1 | 2003 | 296 | 0.040 |
Why?
| | Genetic Markers | 1 | 2002 | 335 | 0.040 |
Why?
| | Decision Support Systems, Clinical | 1 | 2024 | 272 | 0.040 |
Why?
| | Societies, Medical | 1 | 2024 | 899 | 0.040 |
Why?
| | Temperature | 1 | 2023 | 633 | 0.040 |
Why?
| | Graphite | 1 | 2019 | 14 | 0.040 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 345 | 0.040 |
Why?
| | Sulfonamides | 1 | 2002 | 583 | 0.030 |
Why?
| | Dinitrobenzenes | 1 | 2018 | 5 | 0.030 |
Why?
| | Metals | 1 | 2019 | 136 | 0.030 |
Why?
| | Genetic Variation | 1 | 2003 | 972 | 0.030 |
Why?
| | Receptors, IgE | 1 | 2018 | 43 | 0.030 |
Why?
| | Metal Nanoparticles | 1 | 2018 | 80 | 0.030 |
Why?
| | Sex Factors | 1 | 2003 | 2105 | 0.030 |
Why?
| | Lipids | 1 | 2021 | 707 | 0.030 |
Why?
| | Cell Cycle | 1 | 2019 | 598 | 0.030 |
Why?
| | DNA | 1 | 2003 | 1435 | 0.030 |
Why?
| | Morbidity | 1 | 2017 | 322 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1480 | 0.030 |
Why?
| | United States | 2 | 2024 | 16098 | 0.030 |
Why?
| | Microscopy, Polarization | 1 | 2014 | 30 | 0.030 |
Why?
| | Disaccharides | 1 | 2014 | 21 | 0.030 |
Why?
| | Global Health | 1 | 2017 | 403 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 2 | 2005 | 162 | 0.020 |
Why?
| | Neutrophil Infiltration | 1 | 2014 | 104 | 0.020 |
Why?
| | Mesothelioma | 1 | 2014 | 51 | 0.020 |
Why?
| | Hyperplasia | 1 | 2014 | 177 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2021 | 4148 | 0.020 |
Why?
| | Fruit | 1 | 2014 | 146 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2014 | 365 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2014 | 592 | 0.020 |
Why?
| | Adenoma | 1 | 2014 | 218 | 0.020 |
Why?
| | B7-2 Antigen | 1 | 2010 | 27 | 0.020 |
Why?
| | Chemokine CXCL2 | 1 | 2010 | 41 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2014 | 730 | 0.020 |
Why?
| | Indoles | 1 | 2014 | 507 | 0.020 |
Why?
| | Coal Ash | 1 | 2007 | 8 | 0.020 |
Why?
| | TNF Receptor-Associated Factor 2 | 1 | 2007 | 8 | 0.020 |
Why?
| | Epoxy Compounds | 1 | 2007 | 31 | 0.020 |
Why?
| | Inhalation | 1 | 2007 | 29 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 302 | 0.020 |
Why?
| | Carbon | 1 | 2007 | 176 | 0.010 |
Why?
| | Reticulocytes | 1 | 2005 | 17 | 0.010 |
Why?
| | Aged | 1 | 2024 | 26153 | 0.010 |
Why?
| | Micronuclei, Chromosome-Defective | 1 | 2003 | 8 | 0.010 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2003 | 14 | 0.010 |
Why?
| | Lipid Metabolism | 1 | 2007 | 529 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2007 | 1067 | 0.010 |
Why?
| | Homozygote | 1 | 2003 | 199 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 78 | 0.010 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 62 | 0.010 |
Why?
| | Celecoxib | 1 | 2002 | 42 | 0.010 |
Why?
| | Lymphokines | 1 | 2002 | 128 | 0.010 |
Why?
| | Middle Aged | 1 | 2024 | 36215 | 0.010 |
Why?
| | Neutrophils | 1 | 2007 | 1124 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2002 | 376 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2002 | 552 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2002 | 1716 | 0.010 |
Why?
| | Pyrazoles | 1 | 2002 | 517 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2003 | 740 | 0.010 |
Why?
| | Erythrocytes | 1 | 2003 | 748 | 0.010 |
Why?
| | Apoptosis | 1 | 2003 | 2440 | 0.010 |
Why?
|
|
Bauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|